Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares Outstanding
Ratios

Codexis (CDXS) Shares Outstanding (2016 - 2025)

Codexis has reported Shares Outstanding over the past 16 years, most recently at $90.5 million for Q4 2025.

  • For Q4 2025, Shares Outstanding rose 10.54% year-over-year to $90.5 million; the TTM value through Dec 2025 reached $90.5 million, up 10.54%, while the annual FY2025 figure was $90.5 million, 10.54% up from the prior year.
  • Shares Outstanding for Q4 2025 was $90.5 million at Codexis, roughly flat from $90.3 million in the prior quarter.
  • Over five years, Shares Outstanding peaked at $90.5 million in Q4 2025 and troughed at $64.5 million in Q1 2021.
  • A 5-year average of $72.8 million and a median of $69.8 million in 2023 define the central range for Shares Outstanding.
  • Biggest five-year swings in Shares Outstanding: rose 1.08% in 2022 and later grew 27.27% in 2025.
  • Year by year, Shares Outstanding stood at $65.1 million in 2021, then increased by 1.08% to $65.8 million in 2022, then grew by 6.22% to $69.9 million in 2023, then increased by 17.09% to $81.8 million in 2024, then grew by 10.54% to $90.5 million in 2025.
  • Business Quant data shows Shares Outstanding for CDXS at $90.5 million in Q4 2025, $90.3 million in Q3 2025, and $90.3 million in Q2 2025.